Document Detail


The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
MedLine Citation:
PMID:  14577451     Owner:  KIE     Status:  MEDLINE    
Abstract/OtherAbstract:
In this paper, we provide an overview of how the outcomes of the Uruguay Round affected the application of pharmaceutical intellectual property rights globally. Second, we explain how specific pharmaceutical policy tools can help developing states mitigate the worst effects of the TRIPS Agreement. Third, we put forward solutions that could be implemented by the World Bank to help overcome the divide between creating private incentives for research and development of innovative medicines and ensuring access of the poor to medicine. Fourth, we evaluate these solutions on the basis of utilitarian considerations and urge that equitable pricing is morally preferable to the other solutions.
Authors:
Jillian Clare Cohen; Patricia Illingworth
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Developing world bioethics     Volume:  3     ISSN:  1471-8731     ISO Abbreviation:  Dev World Bioeth     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-10-25     Completed Date:  2003-11-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101120122     Medline TA:  Dev World Bioeth     Country:  England    
Other Details:
Languages:  eng     Pagination:  27-48     Citation Subset:  E    
Affiliation:
Department of Philosophy and Religion, 361 Holmes Hall, Northeastern University, Boston, MA 02155-5000, USA. p.illingworth@neu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Developing Countries / economics*
Drug Industry / economics*,  ethics*,  legislation & jurisprudence*
Health Services Accessibility / economics
Health Services Needs and Demand / economics
Intellectual Property*
Internationality*
Jurisprudence
Patents as Topic / legislation & jurisprudence*
Pharmaceutical Preparations / economics*
Social Responsibility
Chemical
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of convective disturbances induced by g-jitter on the periodic precipitation of lysozyme.
Next Document:  Through a glass, darkly: data and uncertainty in the AIDS debate.